Who owns BeOne Medicines Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ONC from SEC Form 13F filings across 284 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 284 institutions disclosed 35.0M shares of BeOne Medicines Ltd. worth $9.95B — about 2.4% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
284
13F holders
$9.95B
value, 2026 filers
2.4%
of shares outstanding (35.0M sh)
48
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ONC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 8.8M | $2.51B | 12.6% | 0.6% | 0.0% |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 5.0M | $1.43B | 0.8% | 0.3% | +0.7% |
| 3 | Capital International Investors | 4.2M | $1.20B | 0.2% | 0.3% | +1.2% |
| 4 | FMR LLC | 2.5M | $706.3M | 0.0% | 0.2% | -32.9% |
| 5 | Capital World Investors | 2.2M | $641.1M | 0.1% | 0.2% | +38.6% |
| 6 | CITADEL ADVISORS LLC | 1.4M | $406.2M | 0.0% | 0.1% | +35.7% |
| 7 | Temasek Holdings (Private) Ltd | 845,729 | $241.0M | 0.6% | 0.1% | -2.0% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 758,752 | $216.2M | 0.0% | 0.1% | +40.6% |
| 9 | BlackRock, Inc. | 694,618 | $197.9M | 0.0% | 0% | +5.2% |
| 10 | MILLENNIUM MANAGEMENT LLC | 543,323 | $154.8M | 0.1% | 0% | +165.2% |
| 11 | MORGAN STANLEY | 497,437 | $141.8M | 0.0% | 0% | +1.0% |
| 12 | Siren, L.L.C. | 465,000 | $132.5M | 2.7% | 0% | 0.0% |
| 13 | BANK OF AMERICA CORP /DE/ | 439,336 | $125.2M | 0.0% | 0% | +8.4% |
| 14 | Baird Financial Group, Inc. | 368,978 | $105.1M | 0.1% | 0% | +5.5% |
| 15 | Man Group plc | 307,463 | $87.6M | 0.1% | 0% | +27.1% |
| 16 | Capital International, Inc./CA/ | 305,477 | $87.1M | 0.6% | 0% | +1.1% |
| 17 | Candriam S.C.A. | 289,735 | $82.5M | 0.4% | 0% | +11.6% |
| 18 | TWO SIGMA INVESTMENTS, LP | 286,552 | $81.7M | 0.1% | 0% | +754.3% |
| 19 | UBS Group AG | 258,589 | $73.7M | 0.0% | 0% | -44.5% |
| 20 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 249,758 | $71.2M | 0.0% | 0% | +125.8% |
| 21 | FIRST TRUST ADVISORS LP | 245,823 | $70.1M | 0.0% | 0% | +1.8% |
| 22 | M&G PLC | 223,445 | $63.7M | 0.3% | 0% | +61.7% |
| 23 | Nuveen, LLC | 201,062 | $57.3M | 0.0% | 0% | +2.4% |
| 24 | JPMORGAN CHASE & CO | 188,405 | $54.6M | 0.0% | 0% | +139.0% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 185,544 | $52.9M | 0.0% | 0% | +0.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.